Zinnia Madon Elavia, CCC-SLP | |
16120 Ne 8th St, Bellevue, WA 98008-3937 | |
(425) 747-4004 | |
(425) 747-1069 |
Full Name | Zinnia Madon Elavia |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 16120 Ne 8th St, Bellevue, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104065929 | NPI | - | NPPES |
7018120 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | LL60032437 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Zinnia Madon Elavia, CCC-SLP 16120 Ne 8th St, Bellevue, WA 98008-3937 Ph: (425) 747-4004 | Zinnia Madon Elavia, CCC-SLP 16120 Ne 8th St, Bellevue, WA 98008-3937 Ph: (425) 747-4004 |
News Archive
Yale researchers have discovered how a novel anti-depressant can take effect in hours, rather than the weeks or months usually required for most drugs currently on the market.
Shionogi & Co., Ltd. and QuatRx Pharmaceuticals Company, a privately-held pharmaceutical company, today announced that they have entered into a worldwide license agreement to develop and market ospemifene, a selective estrogen receptor modulator ("SERM").
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that current and former users of marijuana are more likely to have prediabetes-the state of poor blood sugar control that can progress to type 2 diabetes-than never users of marijuana. However the researchers, led by Mike Bancks (University of Minnesota School of Public Health, Minneapolis, MN, USA) failed to establish a direct link between marijuana use and type 2 diabetes.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that the US Food and Drug Administration (FDA) has approved its orphan drug ERWINAZE (asparaginase Erwinia chrysanthemi) for the treatment of acute lymphoblastic leukemia (ALL) in patients with hypersensitivity to E. coli-derived asparaginase.
On March 20, Andrew Gaumer celebrated the 10th anniversary of his life-saving heart and double-lung transplant. On Mother's Day, his wife, Andrea, gave birth to their first child, a baby boy named Jude. And on June 21, Andrew will celebrate his first Father's Day - a milestone he once feared he would never see.
› Verified 2 days ago
Alexandra Marie Gomez, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1417 116th Ave Ne, Suite 110, Bellevue, WA 98004 Phone: 425-688-5900 Fax: 425-688-5912 | |
Elise Morrison, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5150 Village Park Dr Se, Bellevue, WA 98006 Phone: 425-657-0620 Fax: 425-502-8425 | |
Andrea Nicole Jamieson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16120 Ne 8th St, Bellevue, WA 98008 Phone: 425-747-4004 Fax: 425-747-1069 | |
Mrs. Katherine Jeanne Oberhofer, MS CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1417 116th Ave Ne Ste 110, Bellevue, WA 98004 Phone: 425-688-5911 Fax: 425-688-5912 | |
Mrs. Lori Anne Price, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12 Lummi Key, Bellevue, WA 98006 Phone: 425-643-2919 Fax: 425-657-0691 | |
Mackenzie Bush, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13333 Ne Bel Red Rd Ste 100, Bellevue, WA 98005 Phone: 501-352-0101 | |
Genenvieve Decantis, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5150 Village Park Dr Se, Bellevue, WA 98006 Phone: 425-657-0620 |